Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEPOLIZUMAB Cause Pulmonary function test abnormal? 263 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 263 reports of Pulmonary function test abnormal have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.6% of all adverse event reports for MEPOLIZUMAB.

263
Reports of Pulmonary function test abnormal with MEPOLIZUMAB
0.6%
of all MEPOLIZUMAB reports
2
Deaths
242
Hospitalizations

How Dangerous Is Pulmonary function test abnormal From MEPOLIZUMAB?

Of the 263 reports, 2 (0.8%) resulted in death, 242 (92.0%) required hospitalization, and 5 (1.9%) were considered life-threatening.

Is Pulmonary function test abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 263 reports have been filed with the FAERS database.

What Other Side Effects Does MEPOLIZUMAB Cause?

Asthma (11,033) Dyspnoea (9,192) Wheezing (6,093) Product dose omission issue (5,873) Cough (4,577) Pneumonia (4,107) Therapeutic product effect incomplete (4,106) Drug ineffective (3,880) Loss of personal independence in daily activities (3,566) Fatigue (2,656)

What Other Drugs Cause Pulmonary function test abnormal?

ALBUTEROL (399) PREDNISONE (371) MONTELUKAST (332) OMALIZUMAB (273) TIOTROPIUM (198) BUDESONIDE (189) OSELTAMIVIR (170) AZITHROMYCIN (169) RUPATADINE (168) CEFTRIAXONE (164)

Which MEPOLIZUMAB Alternatives Have Lower Pulmonary function test abnormal Risk?

MEPOLIZUMAB vs MEPROBAMATE MEPOLIZUMAB vs MERCAPTOPURINE MEPOLIZUMAB vs MEROPENEM MEPOLIZUMAB vs MEROPENEM ANHYDROUS MEPOLIZUMAB vs MESALAMINE

Related Pages

MEPOLIZUMAB Full Profile All Pulmonary function test abnormal Reports All Drugs Causing Pulmonary function test abnormal MEPOLIZUMAB Demographics